Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Perrigo (NY: PRGO )

30.56 +0.10 (+0.33%)
Streaming Delayed Price Updated: 11:07 AM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 265,749
Open 30.39
Bid (Size) 30.55 (4)
Ask (Size) 30.57 (2)
Prev. Close 30.46
Today's Range 30.32 - 30.88
52wk Range 26.81 - 40.28
Shares Outstanding 133,714,781
Dividend Yield 3.57%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Insiders Buying DENTSPLY SIRONA And 2 Other Stocks
Although U.S. stocks closed lower on Monday, there were a few notable insider trades. 
Via Benzinga
$1.8M Bet On This Stock? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed slightly higher on Friday, there were a few notable insider trades. 
Via Benzinga

Performance

YTD
-13.21%
-13.21%
1 Month
+10.56%
+10.56%
3 Month
-12.69%
-12.69%
6 Month
-11.27%
-11.27%
1 Year
-5.18%
-5.18%

More News

Read More
Personal Care Industry Poised For Growth: Analyst Initiates Coverage On These 3 Stocks
Via Benzinga
Perrigo Cuts Annual Guidance, This OTC Drug Firm Also Reports Mixed Q3 Earnings
Via Benzinga
Cramer Says This AI Company 'Actually Lived Up To Their Hype': Stock Is Up 148% This Year
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Perrigo Supports Customers through Tough Times, Supporting Shareholders through Changes
Via Benzinga
FDA Approves Over-the-Counter Birth Control Pill. Is the Pill Maker's Stock Set to Soar?
Via The Motley Fool
Perrigo Q1 Earnings Beat Estimates On Strategic Pricing, CEO Plans Retirement
Via Benzinga
Earnings Scheduled For November 7, 2023
Via Benzinga
Preview: Perrigo's Earnings
Via Benzinga
With a Big Catalyst in Hand, Is Perrigo Company a Buy?
Via The Motley Fool
PRGO Stock Alert: Perrigo Climbs on Landmark FDA Birth Control Decision
Via InvestorPlace
First Birth Control Pill For OTC Use In US Lands FDA Approval
Via Benzinga
Perrigo Picks Former Bayer Executive As New CEO
Via Benzinga
$4.5M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
FDA Raises Concerns Regarding Perrigo's OTC Birth Control Pill, Casts Doubts Over Real-World Use
Via Benzinga
FDA Sets New Adcomm Date To Review Perrigo's Oral Contraceptive Pill For OTC Use
Via Benzinga
Earnings Outlook For Perrigo Co
Via Benzinga
Republicans Seek Documents, Schedule Hearing Related To FDA's Response To Baby-Formula Shortage
Via Benzinga
Insiders Selling Perrigo And 3 Other Stocks
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
Via Benzinga
7 Perfect Presents to Gift Your 2023 Stock Portfolio
Via InvestorPlace
Earnings Scheduled For February 27, 2023
Via Benzinga
SWEDEN’S SKINCARE SENSATION ACO EXTENDS PRESENCE INTO US TIMED TO THE HOLIDAY SEASON
From ACO
Via GlobeNewswire
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.